ArticlePloS one2018
Theoretical and experimental study of dual-fiber laser ablation for prostate cancer.
Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Article
- Experimental Evaluation of Different Optical Fibers for Micro-Invasive Soft-Tissue Ablation with a 1064 nm Diode Laser System.Sensors (Basel, Switzerland) · 2026Article
- Modulating the glioma microenvironment with laser interstitial thermal therapy: mechanisms and therapeutic implications.Journal of neuro-oncology · 2025Review
- Optimization of laser dosimetry based on patient-specific anatomical models for the ablation of pancreatic ductal adenocarcinoma tumor.Scientific reports · 2023Article
- Measurement of Ex Vivo Liver, Brain and Pancreas Thermal Properties as Function of Temperature.Sensors (Basel, Switzerland) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Single-fiber laser treatment of the prostate has been widely accepted in the clinic due to its minimal invasiveness and high controllability. However, for large tumors, multiple insertions of the laser probe would be needed to achieve full coverage of the tumor, increasing the complexity of the treatment and occasionally resulting in the incomplete killing of tumor cells due to a mismatch between the planned insertion location and the actual probe insertion location. Treatment with a dual-fiber laser results in greater lesion coverage following a single insertion of the probe, with the lesion coverage being even greater than the sum of the coverage of two sequential insertion of a single-fiber laser probe, potentially reducing treatment time and clinical complications. Both theoretical and experimental analyses have been performed to evaluate the proposed dual-fiber laser treatment. A finite element model was established to simulate the treatment process. The simulation results indicated that there is a clear difference between the ablation coverage created using dual-fiber laser ablation and that created using the superposition of sequential single-fiber laser ablation. In addition, the coverage is dependent on the spacing distance between the two fibers. Both ex vivo and in vivo canine prostate tissues were treated by dual-fiber laser ablation, with lesions analyzed by magnetic resonance imaging (MRI), ultrasound imaging, and pathology. The results demonstrate that dual-fiber laser ablation can markedly increase the range of the ablation zone when compared with single-fiber modes. The safety and feasibility of dual-fiber laser treatment has been confirmed, and a treatment plan using dual-fiber laser ablation has also been proposed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.